Saturday, February 24, 2024
6:30 AM-8:00 AM ET
Division of Allergy, Pulmonary, and Critical Care Medicine
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee
Allergy and Immunology
Associate Director
Brigham and Women’s Hospital Mastocytosis Center
Boston, Massachusetts
University of Utah School of Medicine
President and Chief Scientific Officer
ARUP Laboratories
Salt Lake City, Utah
Assistant Professor of Medicine
Mayo Clinic College of Medicine and Science
Rochester, Minnesota
This program is not sponsored or programmed by the AAAAI.
This program is not certified for continuing education credit. The content and opinions expressed are those of the sponsor and/or presenter(s) and are not necessarily those of the AAAAI.
There is no fee to attend this Non-CME Educational Program; however, seating is limited. Preregistration does not guarantee seating. We recommend arriving at the symposium location early.
Program Description
Don’t miss this Medical Jeopardy activity, designed to provide an informative, unique, and engaging educational approach to learning about nonadvanced systemic mastocytosis (SM)! Learners will participate in a modified “Jeopardy” game, and each team will be led by our expert faculty contestants, with the didactic content presented as an explanation of the correct answer to each question. Topics covered will include pathophysiology, diagnosis, treatment paradigms, including the use of tyrosine kinase inhibitors, and real-world strategies for patient management and education. Join us for this fun, exciting, and competitive program and see if you have what it takes to win!
Target Audience
This activity is designed to educate clinical immunologists/allergists, dermatologists, gastroenterologists, pathologists, hematologists, and other specialist clinicians who diagnose or manage nonadvanced SM.
Educational Objectives
- Discuss the causes and consequences of nonadvanced SM, focusing on potential clinical manifestations and the rationale for new targeted therapies
- Differentially diagnose SM, including indolent disease, based on symptoms and appropriate use of laboratory and genetic testing
- Describe recent clinical trial evidence and regulatory status for targeted treatment options in nonadvanced SM
- Individualize treatment of nonadvanced SM that reflects clinical evidence for efficacy and safety, patient-reported outcomes, and shared clinical decision-making
Program Agenda
6:30–6:40 am Introductions and Preactivity Questionnaire
6:40–7:45 am CME Jeopardy
7:45–8:00 am Postactivity Questionnaire and Question & Answer Session
Disclosures of Conflicts of Interest
Integritas Communications adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content are required to disclose all financial relationships with any ineligible company within the past 24 months to Integritas. All financial relationships reported are identified as relevant and mitigated by Integritas in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Integritas to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integritas Communications does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact us prior to the live event at info@exchangecme.com.